The cytosolic tryparedoxin of Leishmania infantum is essential for parasite survival

International Journal for Parasitology

Volumn 39, Issue 6, 2009, Pages 703-711

  Romao, Susana ^a   Castro, Helena ^a   Sousa, Carla ^a   Carvalho, Sandra ^a   Tomás, Ana M ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Drug target; Leishmania infantum; Tryparedoxin; Visceral leishmaniasis

Indexed keywords

CHROMOSOME; DNA; DRUG; GENE EXPRESSION; HYDROGEN PEROXIDE; LIFE CYCLE; PROTEIN; PROTOZOAN; SURVIVAL; VIRULENCE;

ANIMALS; CELL SURVIVAL; CYTOSOL; GENE DELETION; GENES, ESSENTIAL; GENETIC COMPLEMENTATION TEST; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MACROPHAGES, PERITONEAL; MICE; THIOREDOXINS;

EID: 61349124238     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2008.11.009     Document Type: Article

References (50)

1. Allaoui A., Francois C., Zemzoumi K., Guilvard E., and Ouaissi A. Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele. Mol. Microbiol. 32 (1999) 1273-1286
2. Alphey M.S., Tetaud E., Gourley D.G., Fairlamb A.H., and Hunter W.N. Crystallization of recombinant Crithidia fasciculata tryparedoxin. J. Struct. Biol. 126 (1999) 76-79
3. Alphey M.S., Gabrielsen M., Micossi E., Leonard G.A., McSweeney S.M., Ravelli R.B., Tetaud E., Fairlamb A.H., Bond C.S., and Hunter W.N. Tryparedoxins from Crithidia fasciculata and Trypanosoma brucei: photoreduction of the redox disulfide using synchrotron radiation and evidence for a conformational switch implicated in function. J. Biol. Chem. 278 (2003) 25919-25925
4. Ariyanayagam M.R., Oza S.L., Guther M.L., and Fairlamb A.H. Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome. Biochem. J. 391 (2005) 425-432
5. Arner E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
6. Beverley S.M., and Clayton C.E. Transfection of Leishmania and Trypanosoma brucei by electroporation. Methods Mol. Biol. 21 (1993) 333-348
7. Billiet L., Furman C., Larigauderie G., Copin C., Brand K., Fruchart J.C., and Rouis M. Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1β expression in human monocyte-derived macrophages. J. Biol. Chem. 280 (2005) 40310-40318
8. Boucher N., McNicoll F., Laverdiere M., Rochette A., Chou M.N., and Papadopoulou B. The ribosomal RNA gene promoter and adjacent cis-acting DNA sequences govern plasmid DNA partitioning and stable inheritance in the parasitic protozoan Leishmania. Nucleic Acids Res. 32 (2004) 2925-2936
9. Carvalho S., Cruz T., Santarém N., Castro H., Costa V., and Tomás A.M. Heme as a source of iron to Leishmania infantum amastigotes. Acta Trop. 109 (2009) 131-135
10. Castro H., Sousa C., Santos M., Cordeiro-da-Silva A., Flohé L., and Tomás A.M. Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum. Free Radic. Biol. Med. 33 (2002) 1552-1562
11. Castro H., Sousa C., Novais M., Santos M., Budde H., Cordeiro-da-Silva A., Flohé L., and Tomás A.M. Two linked genes of Leishmania infantum encode tryparedoxins localised to cytosol and mitochondrion. Mol. Biochem. Parasitol. 136 (2004) 137-147
12. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., Alvar J., and Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat. Rev. Microbiol. 5 (2007) 873-882
13. Comini M.A., Guerrero S.A., Haile S., Menge U., Lunsdorf H., and Flohé L. Validation of Trypanosoma brucei trypanothione synthetase as drug target. Free Radic. Biol. Med. 36 (2004) 1289-1302
14. Comini M.A., Krauth-Siegel R.L., and Flohé L. Depletion of the thioredoxin homologue tryparedoxin impairs antioxidative defence in African trypanosomes. Biochem. J. 402 (2007) 43-49
15. Cruz A.K., Titus R., and Beverley S.M. Plasticity in chromosome number and testing of essential genes in Leishmania by targeting. Proc. Natl. Acad. Sci. USA 90 (1993) 1599-1603
16. Dormeyer M., Reckenfelderbaumer N., Ludemann H., and Krauth-Siegel R.L. Trypanothione-dependent synthesis of deoxyribonucleotides by Trypanosoma brucei ribonucleotide reductase. J. Biol. Chem. 276 (2001) 10602-10606
17. Dumas C., Ouellette M., Tovar J., Cunningham M.L., Fairlamb A.H., Tamar S., Olivier M., and Papadopoulou B. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. Embo J. 16 (1997) 2590-2598
18. Eklund H., Gleason F.K., and Holmgren A. Structural and functional relations among thioredoxins of different species. Proteins 11 (1991) 13-28
19. Fairlamb A.H., Blackburn P., Ulrich P., Chait B.T., and Cerami A. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 227 (1985) 1485-1487
20. Fairlamb A.H., and Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu. Rev. Microbiol. 46 (1992) 695-729
21. Gantt K.R., Goldman T.L., McCormick M.L., Miller M.A., Jeronimo S.M., Nascimento E.T., Britigan B.E., and Wilson M.E. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167 (2001) 893-901
22. Genest P.A., ter Riet B., Dumas C., Papadopoulou B., van Luenen H.G., and Borst P. Formation of linear inverted repeat amplicons following targeting of an essential gene in Leishmania. Nucleic Acids Res. 33 (2005) 1699-1709
23. Gommel D.U., Nogoceke E., Morr M., Kiess M., Kalisz H.M., and Flohé L. Catalytic characteristics of tryparedoxin. Eur. J. Biochem. 248 (1997) 913-918
24. Grondin K., Kundig C., Roy G., and Ouellette M. Linear amplicons as precursors of amplified circles in methotrexate-resistant Leishmania tarentolae. Nucleic Acids Res. 26 (1998) 3372-3378
25. Heise N., and Opperdoes F.R. Purification, localisation and characterisation of glucose-6-phosphate dehydrogenase of Trypanosoma brucei. Mol. Biochem. Parasitol. 99 (1999) 21-32
26. Hofmann B., Budde H., Bruns K., Guerrero S.A., Kalisz H.M., Menge U., Montemartini M., Nogoceke E., Steinert P., Wissing J.B., Flohé L., and Hecht H.J. Structures of tryparedoxins revealing interaction with trypanothione. Biol. Chem. 382 (2001) 459-471
27. Hsu J.Y., Lin Y.C., Chiang S.C., and Lee S.T. Divergence of trypanothione-dependent tryparedoxin cascade into cytosolic and mitochondrial pathways in arsenite-resistant variants of Leishmania amazonensis. Mol. Biochem. Parasitol. 157 (2008) 193-204
28. Kelly J.M., Ward H.M., Miles M.A., and Kendall G. A shuttle vector which facilitates the expression of transfected genes in Trypanosoma cruzi and Leishmania. Nucleic Acids Res. 20 (1992) 3963-3969
29. Kelly J.M. Isolation of DNA and RNA from Leishmania. Methods Mol. Biol. 21 (1993) 123-131
30. Konig J., and Fairlamb A.H. A comparative study of type I and type II tryparedoxin peroxidases in Leishmania major. FEBS J. 274 (2007) 5643-5658
31. Lambeth J.D., Kawahara T., and Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43 (2007) 319-331
32. Lopez J.A., Carvalho T.U., de Souza W., Flohé L., Guerrero S.A., Montemartini M., Kalisz H.M., Nogoceke E., Singh M., Alves M.J., and Colli W. Evidence for a trypanothione-dependent peroxidase system in Trypanosoma cruzi. Free Radic. Biol. Med. 28 (2000) 767-772
33. Ludemann H., Dormeyer M., Sticherling C., Stallmann D., Follmann H., and Krauth-Siegel R.L. Trypanosoma brucei tryparedoxin, a thioredoxin-like protein in African trypanosomes. FEBS Lett. 431 (1998) 381-385
34. Martyn D.C., Jones D.C., Fairlamb A.H., and Clardy J. High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity. Bioorg. Med. Chem. Lett. 17 (2007) 1280-1283
35. Melo R.C., Fabrino D.L., D'Avila H., Teixeira H.C., and Ferreira A.P. Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol. Int. 27 (2003) 853-861
36. Mottram J.C., Souza A.E., Hutchison J.E., Carter R., Frame M.J., and Coombs G.H. Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc. Natl. Acad. Sci. USA 93 (1996) 6008-6013
37. Mottram J.C., McCready B.P., Brown K.G., and Grant K.M. Gene disruptions indicate an essential function for the LmmCRK1 cdc2-related kinase of Leishmania mexicana. Mol. Microbiol. 22 (1996) 573-583
38. Mukbel R.M., Patten Jr. C., Gibson K., Ghosh M., Petersen C., and Jones D.E. Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. Am. J. Trop. Med. Hyg. 76 (2007) 669-675
39. Nogoceke E., Gommel D.U., Kiess M., Kalisz H.M., and Flohé L. A unique cascade of oxidoreductases catalyses trypanothione-mediated peroxide metabolism in Crithidia fasciculata. Biol. Chem. 378 (1997) 827-836
40. Onn I., Milman-Shtepel N., and Shlomai J. Redox potential regulates binding of universal minicircle sequence binding protein at the kinetoplast DNA replication origin. Eukaryot. Cell 3 (2004) 277-287
41. Pallis M., Bradshaw T.D., Westwell A.D., Grundy M., Stevens M.F., and Russell N. Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compounds. Biochem. Pharmacol. 66 (2003) 1695-1705
42. Rubartelli A., Bajetto A., Allavena G., Wollman E., and Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267 (1992) 24161-24164
43. Sambrook J.F., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
44. Sereno D., and Lemesre J.L. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob. Agents Chemother. 41 (1997) 972-976
45. Steinert P., Plank-Schumacher K., Montemartini M., Hecht H.J., and Flohé L. Permutation of the active site motif of tryparedoxin 2. Biol. Chem. 381 (2000) 211-219
46. Sousa Silva M., Ferreira A.E., Tomas A.M., Cordeiro C., and Ponces Freire A. Quantitative assessment of the glyoxalase pathway in Leishmania infantum as a therapeutic target by modelling and computer simulation. FEBS J. 272 (2005) 2388-2398
47. Trujillo M., Budde H., Pineyro M.D., Stehr M., Robello C., Flohé L., and Radi R. Trypanosoma brucei and Trypanosoma cruzi tryparedoxin peroxidases catalytically detoxify peroxynitrite via oxidation of fast reacting thiols. J. Biol. Chem. 279 (2004) 34175-34182
48. Wilkinson S.R., Temperton N.J., Mondragon A., and Kelly J.M. Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi. J. Biol. Chem. 275 (2000) 8220-8225
49. Wilkinson S.R., Meyer D.J., Taylor M.C., Bromley E.V., Miles M.A., and Kelly J.M. The Trypanosoma cruzi enzyme TcGPXI is a glycosomal peroxidase and can be linked to trypanothione reduction by glutathione or tryparedoxin. J. Biol. Chem. 277 (2002) 17062-17071
50. Wilkinson S.R., Horn D., Prathalingam S.R., and Kelly J.M. RNA interference identifies two hydroperoxide metabolizing enzymes that are essential to the bloodstream form of the African trypanosome. J. Biol. Chem. 278 (2003) 31640-31646